Liver biopsy in the post-hepatitis C virus era in Japan

doi:10.3748/wjg.v30.i14.1949

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 30, Issue 14

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1840)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-8) series.

Item

Count

PDF

HTML

1247

Figures (1-8)

157

Sum=1466

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

232

Sum=301

Apr 14, 2024 (publication date) through Dec 22, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Gastroenterol. Apr 14, 2024; 30(14): 1949-1957
Published online Apr 14, 2024. doi: 10.3748/wjg.v30.i14.1949

Liver biopsy in the post-hepatitis C virus era in Japan

Yoshihiro Ikura, Takako Okubo, Yasuhiro Sakai

Yoshihiro Ikura, Takako Okubo, Department of Pathology, Takatsuki General Hospital, Takatsuki 569-1192, Osaka Prefecture, Japan

Yasuhiro Sakai, Department of Pathology, Kansai Medical University Medical Center, Moriguchi 570-8507, Japan

Author contributions: Ikura Y contributed to the conception and drafting of the manuscript; Ikura Y, Okubo T, and Sakai Y contributed to critical revisions of the manuscript.

Conflict-of-interest statement: The authors declare that they have no conflicts of interest related to this article.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: Https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Yoshihiro Ikura, DSc, MD, Chief Doctor, Professor, Department of Pathology, Takatsuki General Hospital, 1-3-13, Kosobecho, Takatsuki 569-1192, Osaka Prefecture, Japan. ikura@ajk.takatsuki-hp.or.jp

Received: December 26, 2023
Peer-review started: December 26, 2023
First decision: January 24, 2024
Revised: February 5, 2024
Accepted: March 25, 2024
Article in press: March 25, 2024
Published online: April 14, 2024
Processing time: 108 Days and 9.8 Hours

Core Tip

Core Tip: Over the past 30 years in Japan, liver biopsies for assessing hepatitis C virus (HCV) hepatitis and HCV-related liver cancer were common but declined due to advanced treatments and imaging. This shift decreased diagnostic opportunities and eroded general pathologists’ confidence in conducting liver biopsies. This editorial outlines key challenges: Understanding steatotic liver diseases as independent conditions, caution in diagnosing nodular lesions to prevent misinterpretation, and addressing hepatic injuries caused by immune checkpoint inhibitors. It stresses the need for pathologists to adapt to evolving liver disease landscapes and approach biopsies meticulously.